Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Genetic Testing

CSF2RA Gene Surfactant Metabolism Dysfunction Type 4 Genetic Test

This genetic test identifies mutations in the CSF2RA gene, which can cause surfactant metabolism dysfunction, a condition affecting lung function. It uses Next Generation Sequencing (NGS) technology.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Saliva sample. Confirm specific requirements with the laboratory before booking.
Results
Confirm turnaround time with the laboratory before booking.
Preparation
A clinical history assessment and genetic counseling session are recommended before the test. Discuss specific preparation needs with your doctor or the laboratory.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CSF2RA Gene Surfactant Metabolism Dysfunction Type 4 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Chronic respiratory distress
  • ✓Unexplained lung disease
  • ✓Family history of surfactant metabolism dysfunction
  • ✓Suspected inherited metabolic disorder affecting lungs
  • ✓Evaluation for targeted therapies
02

In plain language

What this test helps you understand

Identifies genetic mutations in the CSF2RA gene associated with surfactant metabolism dysfunction, aiding in the diagnosis of this rare metabolic disorder.
The CSF2RA Gene Surfactant Metabolism Dysfunction Type 4 NGS Genetic DNA Test is an advanced diagnostic tool using Next Generation Sequencing (NGS) technology. It identifies genetic mutations linked to surfactant metabolism dysfunction, a condition that can cause significant respiratory problems. Understanding the genetic basis of this condition is crucial for managing metabolic disorders affecting the lungs. This test specifically analyzes the CSF2RA gene, which is vital for surfactant metabolism. By examining the patient's genetic material, healthcare providers can determine if inherited mutations are present, potentially leading to lung function issues. Individuals experiencing chronic respiratory distress, unexplained lung disease, or those with a family history of surfactant metabolism dysfunction may benefit from this test. The test provides accurate diagnosis, informs treatment options, aids in family planning, and may guide access to targeted therapies. Results indicate the presence of specific genetic mutations. Discussing these results with a healthcare provider is essential for understanding implications and next steps, such as potential treatments or further investigations.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history assessment and genetic counseling session are recommended before the test. Discuss specific preparation needs with your doctor or the laboratory.
SampleBlood sample (EDTA tube) or Saliva sample. Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) of the CSF2RA gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific mutations in the CSF2RA gene but may not detect all possible genetic variations. Results should be interpreted in the context of clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This is a rare genetic disorder affecting the lungs due to problems with surfactant, a substance essential for breathing. It is caused by mutations in the CSF2RA gene.
Individuals with symptoms like chronic respiratory problems, unexplained lung disease, or a family history of this condition should discuss this test with their doctor.
The test involves analyzing a sample of your blood or saliva to look for specific genetic changes in the CSF2RA gene using Next Generation Sequencing (NGS).
A healthcare provider will interpret the results in the context of your medical history and symptoms. Genetic counseling is often recommended to understand the implications.
Yes, genetic counseling before and after the test is highly recommended to understand the test's purpose, potential results, and their implications for you and your family.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Beta CTx Beta Crosslaps Collagen Type 1 C-Telopeptide Test

The Beta CTx test measures bone resorption markers to help assess bone health and osteoporosis risk.

Learn more →

Bcell Rearrangement Detection Test

The Bcell Rearrangement Detection Test helps diagnose leukemia by identifying genetic changes in B cells. It's a key tool for hematologists and oncologists.

Learn more →

Dpd Gene Mutations 5Fu Toxicity Detection Test

This genetic test identifies mutations in the DPD gene, helping predict the risk of severe side effects from the chemotherapy drug 5-fluorouracil (5FU).

Learn more →

Ganciclovir Resistance Detection Test

This test checks for genetic changes in the cytomegalovirus (CMV) that may make it resistant to the antiviral medication Ganciclovir. It helps guide treatment decisions, especially for patients with weakened immune systems.

Learn more →
Chat on WhatsApp